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Purpose
Inflammatory brain disease causes severe psychiatric and
neurological deficits in previously healthy children. The
aim of this study was to report characteristic clinical
features and outcomes of children diagnosed with Anti-
N-methyl-D-aspartate receptor (NMDAR) encephalitis, a
newly recognized anti-neuronal antibody-mediated
inflammatory brain disease, seen by the Rheumatology
service over an 18 month period.
Methods
Over an 18-month period (July 2009-Dec 2010), consecu-
tive children presenting with newly acquired psychiatric
and/or neurologic deficits consistent with anti-NMDAR
encephalitis and evidence of central nervous system
(CNS) inflammation were screened. Serum and cere-
brospinal fluid (CSF) samples were obtained and sent for
anti-NMDAR antibody testing. Children were included
in the study if they had confirmatory evidence of these
antibodies in the serum and/or CSF. Details of clinical
presentation and results of investigations, including
inflammatory markers, CSF studies and neuroimaging,
were documented. Type and duration of treatment and
outcomes at last follow-up were evaluated.
Results
Over the study period a total of 18 children presented
with clinical features compatible with anti-NMDAR
encephalitis including psychiatric manifestations, seizures
and/or movement disorders. Four children (22%) had
positive anti-NMDAR antibodies and were diagnosed
with anti-NMDAR encephalitis. These included one male
and three females, with a median age of 12.8 years (range
3-16 years). The remaining 14 children were subse-
quently diagnosed with 1) primary CNS vasculitis (4); 2)
post-infectious inflammatory brain disease (2); 3) chan-
nelopathy (1); 4) reversible splenial lesions syndrome (1);
5) epilepsy (1); and 6) inflammatory brain disease NYD
(5). All children with anti-NMDAR encephalitis pre-
sented with neuropsychiatric deficits including, seizures,
speech disorder, sleep disturbance, and fluctuating level
of consciousness. The three older patients also had pro-
minent psychiatric features, while the younger child had
significant autonomic instability and prominent involun-
tary movement disorder. None had an underlying tumor.
Immunosuppressive therapy with intravenous immuno-
globulin, steroids and/or rituximab, resulted in near or
complete recovery; however, two of the patients had early
relapse requiring re-treatment.
Conclusion
Anti-NMDAR encephalitis is an important, reversible
cause of neuropsychiatric deficits in children that must
be included in the differential diagnosis of CNS vasculi-
tis and other inflammatory brain diseases. Early diagno-
sis and treatment are essential for neurologic recovery.
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